Featured
Discordances in Perceptions of Shared Decision-making Among Patients With Retinal Diseases and Their Care Teams
Better communication can increase patient and provider understanding.
By John S. Pollack, MD, W. Lloyd Clark, MD, Darius M. Moshfeghi, MD, et al.
Clinical Trials in Retinal Vein Occlusion
Recent trials have explored a variety of interventions to minimize vision loss.
By Neesurg Mehta, MD, Susanna S. Park, MD, PhD
Combination Laser and Anti-VEGF for Retinal Ischemic Areas
Targeted laser approach may not enhance treatment effect.
By Nitish Mehta, MD, Yasha Modi, MD
Diagnosis and Management of Retinal Vasculitis
Investigate thoroughly and tailor treatment to underlying etiology.
By Homaira Ayesha Hossain, MD, Ghazala Datoo O'Keefe, MD
An Update on Susac Syndrome
Multispecialty collaboration is key to good outcomes.
By Dinah Zur, MD, Zohar Habot-Wilner, MD
Web Exclusives
The Virtual Meeting Setup for Retina Specialists
The right equipment makes interviews, meetings, and conferences go smoothly.
By Jennifer Ford, senior managing editor
Departments
UPFRONT: Scope of Practice in Ophthalmology
By Peter K. Kaiser, MD
UVEITIS CORNER: A Deep Dive Into Uveitis Practice
Uveitis specialists share pearls for the retina community.
By Sruthi Arepalli, MD, Ramana Moorthy, MD, Steven Yeh, MD, et al.
CODING Q&A: Avoiding Audit Traps for Intravitreal Injections
Medicare pays out a lot of money for these treatments, so expect close scrutiny.
By Suzanne L. Corcoran, COE
News
SUBSPECIALTY NEWS: Geographic atrophy lesion growth slowed with pegcetacoplan, new data on extended-duration therapies, and more.
By Rochelle Nataloni, contributing writer